Thioguanine or tioguanine

Cell Line Origin Human skin fibroblast, thioguanine resistant Cell Line Description Primary fibroblasts selected for resistance to 5&#956g/ml thioguanine. Application Genetic studies DNA Profile STR-PCR Data: Amelogenin: X,Y CSF1PO: 11,12 D13S317:

Application Used in hybridoma formation applications as a selection agent. Biochem/physiol Actions Ribosylated and phosphorylated by the same pathway as natural purine bases as the nucleotide, inhibits a variety of cellular processes involved in

6-Thioguanine is a variant of guanine with hydrogen bonding at the N-7 of the purine ring. Its association with cytosine alters the dimension of the base stacking.

6-Thioguanine is a variant of guanine with hydrogen bonding at the N-7 of the purine ring. Its association with cytosine alters the dimension of the base stacking.

6-Thioguanine is a variant of guanine with hydrogen bonding at the N-7 of the purine ring. Its association with cytosine alters the dimension of the base stacking.

6-Thioguanine is a variant of guanine with hydrogen bonding at the N-7 of the purine ring. Its association with cytosine alters the dimension of the base stacking.

6-Thioguanine is a variant of guanine with hydrogen bonding at the N-7 of the purine ring. Its association with cytosine alters the dimension of the base stacking.

Please inquire for bulk quantity, pricing, and packaging options. Application Tetrakis(dimethylamido)titanium(IV) (TDMAT) is a precursor to titanium nitride (TiN) thin films by organometallic chemical vapor deposition (OMCVD) and titanium dioxide

Please inquire for bulk quantity, pricing, and packaging options. Application Tetrakis(dimethylamido)titanium(IV) (TDMAT) is a precursor to titanium nitride (TiN) thin films by organometallic chemical vapor deposition (OMCVD) and titanium dioxide

Atomic number of base material: 22 Titanium Application Precursors Packaged for Depositions Systems The product is a precursor for the deposition of titanium dioxide thin films by atomic layer deposition with water.

Potent competitive gamma-aminobutyric acid type A (GABAA) receptor antagonist and glycine receptor agonist. Weak nicotinic acetylcholine receptor agonist.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the